O	0	6	Brick1	Brick1	NN	B-NP
O	7	9	is	be	VBZ	B-VP
O	10	12	an	an	DT	B-NP
O	13	22	essential	essential	JJ	I-NP
O	23	32	regulator	regulator	NN	I-NP
O	33	35	of	of	IN	B-PP
O	36	41	actin	actin	NN	B-NP
B-Cellular_component	42	54	cytoskeleton	cytoskeleton	NN	I-NP
O	55	63	required	require	VBN	B-VP
O	64	67	for	for	IN	B-PP
B-Developing_anatomical_structure	68	77	embryonic	embryonic	JJ	B-NP
O	78	89	development	development	NN	I-NP
O	90	93	and	and	CC	O
B-Cell	94	98	cell	cell	NN	B-NP
O	99	113	transformation	transformation	NN	I-NP
O	113	114	.	.	.	O

O	116	122	Brick1	Brick1	NN	B-NP
O	123	124	(	(	(	O
O	124	128	Brk1	Brk1	NN	B-NP
O	128	129	)	)	)	O
O	130	132	is	be	VBZ	B-VP
O	133	136	the	the	DT	B-NP
O	137	141	less	less	JJR	I-NP
O	141	142	-	-	HYPH	I-NP
O	142	149	studied	study	VBN	I-NP
O	150	159	component	component	NN	I-NP
O	160	162	of	of	IN	B-PP
O	163	166	the	the	DT	B-NP
O	167	171	Wave	Wave	NN	I-NP
O	171	172	/	/	SYM	B-NP
O	172	176	Scar	Scar	NN	I-NP
O	177	184	pathway	pathway	NN	I-NP
O	185	193	involved	involve	VBN	B-VP
O	194	196	in	in	IN	B-PP
O	197	200	the	the	DT	B-NP
O	201	209	branched	branch	VBN	I-NP
O	210	220	nucleation	nucleation	NN	I-NP
O	221	223	of	of	IN	B-PP
O	224	229	actin	actin	NN	B-NP
B-Cellular_component	230	236	fibers	fiber	NNS	I-NP
O	236	237	.	.	.	O

O	238	241	The	The	DT	B-NP
O	242	250	clinical	clinical	JJ	I-NP
O	251	260	relevance	relevance	NN	I-NP
O	261	263	of	of	IN	B-PP
O	264	268	Brk1	Brk1	NN	B-NP
O	269	271	is	be	VBZ	B-VP
O	272	282	emphasized	emphasize	VBN	I-VP
O	283	285	by	by	IN	B-PP
O	286	297	correlative	correlative	JJ	B-NP
O	298	302	data	datum	NNS	I-NP
O	303	310	showing	show	VBG	B-VP
O	311	315	that	that	IN	B-SBAR
O	316	319	Von	Von	NNP	B-NP
O	320	326	Hippel	Hippel	NNP	I-NP
O	326	327	-	-	HYPH	I-NP
O	327	333	Lindau	Lindau	NNP	I-NP
O	334	335	(	(	(	O
O	335	338	VHL	VHL	NNP	B-NP
O	338	339	)	)	)	O
O	340	348	patients	patient	NNS	B-NP
O	349	353	that	that	WDT	B-NP
O	354	358	also	also	RB	B-ADVP
O	359	363	lose	lose	VBP	B-VP
O	364	367	the	the	DT	B-NP
O	368	372	BRK1	BRK1	NN	I-NP
O	373	377	gene	gene	NN	I-NP
O	378	381	are	be	VBP	B-VP
O	382	391	protected	protect	VBN	I-VP
O	392	399	against	against	IN	B-PP
O	400	403	the	the	DT	B-NP
O	404	415	development	development	NN	I-NP
O	416	418	of	of	IN	B-PP
B-Cancer	419	425	tumors	tumor	NNS	B-NP
O	425	426	.	.	.	O

O	427	431	This	This	DT	B-NP
O	432	441	contrasts	contrast	VBZ	B-VP
O	442	446	with	with	IN	B-PP
O	447	453	recent	recent	JJ	B-NP
O	454	462	evidence	evidence	NN	I-NP
O	463	473	suggesting	suggest	VBG	B-VP
O	474	478	that	that	IN	B-SBAR
O	479	482	the	the	DT	B-NP
O	483	487	Wave	Wave	NNP	I-NP
O	488	495	complex	complex	NN	I-NP
O	496	499	may	may	MD	B-VP
O	500	508	function	function	VB	I-VP
O	509	511	as	as	IN	B-PP
O	512	514	an	an	DT	B-NP
O	515	523	invasion	invasion	NN	I-NP
O	524	534	suppressor	suppressor	NN	I-NP
O	535	537	in	in	IN	B-PP
B-Cancer	538	548	epithelial	epithelial	JJ	B-NP
I-Cancer	549	556	cancers	cancer	NNS	I-NP
O	556	557	.	.	.	O

O	558	562	Here	Here	RB	B-ADVP
O	562	563	,	,	,	O
O	564	566	we	we	PRP	B-NP
O	567	571	show	show	VBP	B-VP
O	572	576	that	that	IN	B-SBAR
O	577	580	the	the	DT	B-NP
O	581	595	downregulation	downregulation	NN	I-NP
O	596	598	of	of	IN	B-PP
O	599	603	Brk1	Brk1	NN	B-NP
O	604	611	results	result	VBZ	B-VP
O	612	614	in	in	IN	B-PP
O	615	623	abnormal	abnormal	JJ	B-NP
O	624	629	actin	actin	NN	I-NP
B-Cellular_component	630	636	stress	stress	NN	I-NP
I-Cellular_component	637	642	fiber	fiber	NN	I-NP
O	643	652	formation	formation	NN	I-NP
O	653	656	and	and	CC	O
O	657	665	vinculin	vinculin	NN	B-NP
O	666	678	distribution	distribution	NN	I-NP
O	679	682	and	and	CC	O
O	683	687	loss	loss	NN	B-NP
O	688	690	of	of	IN	B-PP
O	691	695	Arp2	Arp2	NN	B-NP
O	695	696	/	/	SYM	B-NP
O	696	697	3	3	CD	I-NP
O	698	701	and	and	CC	O
O	702	706	Wave	Wave	NNP	B-NP
O	707	715	proteins	protein	NNS	I-NP
O	716	718	at	at	IN	B-PP
O	719	722	the	the	DT	B-NP
B-Cell	723	731	cellular	cellular	JJ	I-NP
O	732	743	protrusions	protrusion	NNS	I-NP
O	743	744	.	.	.	O

O	745	749	Brk1	Brk1	NN	B-NP
O	750	752	is	be	VBZ	B-VP
O	753	761	required	require	VBN	I-VP
O	762	765	for	for	IN	B-PP
B-Cell	766	770	cell	cell	NN	B-NP
O	771	784	proliferation	proliferation	NN	I-NP
O	785	788	and	and	CC	O
B-Cell	789	793	cell	cell	NN	B-NP
O	794	808	transformation	transformation	NN	I-NP
O	809	811	by	by	IN	B-PP
O	812	821	oncogenes	oncogene	NNS	B-NP
O	821	822	.	.	.	O

O	823	825	In	In	IN	B-PP
O	826	834	addition	addition	NN	B-NP
O	834	835	,	,	,	O
O	836	840	Brk1	Brk1	NN	B-NP
O	841	855	downregulation	downregulation	NN	I-NP
O	856	863	results	result	VBZ	B-VP
O	864	866	in	in	IN	B-PP
O	867	876	defective	defective	JJ	B-NP
O	877	888	directional	directional	JJ	I-NP
O	889	898	migration	migration	NN	I-NP
O	899	902	and	and	CC	O
O	903	911	invasive	invasive	JJ	B-NP
O	912	918	growth	growth	NN	I-NP
O	919	921	in	in	IN	B-PP
B-Cell	922	927	renal	renal	JJ	B-NP
I-Cell	928	932	cell	cell	NN	I-NP
I-Cell	933	942	carcinoma	carcinoma	NN	I-NP
I-Cell	943	948	cells	cell	NNS	I-NP
O	949	951	as	as	RB	B-CONJP
O	952	956	well	well	RB	I-CONJP
O	957	959	as	as	IN	I-CONJP
O	960	962	in	in	IN	B-PP
O	963	968	other	other	JJ	B-NP
B-Cell	969	974	tumor	tumor	NN	I-NP
I-Cell	975	979	cell	cell	NN	I-NP
O	980	985	types	type	NNS	I-NP
O	985	986	.	.	.	O

O	987	994	Finally	Finally	RB	B-ADVP
O	994	995	,	,	,	O
O	996	1003	genetic	genetic	JJ	B-NP
O	1004	1012	ablation	ablation	NN	I-NP
O	1013	1015	of	of	IN	B-PP
O	1016	1020	Brk1	Brk1	NN	B-NP
O	1021	1028	results	result	VBZ	B-VP
O	1029	1031	in	in	IN	B-PP
O	1032	1040	dramatic	dramatic	JJ	B-NP
O	1041	1048	defects	defect	NNS	I-NP
O	1049	1051	in	in	IN	B-PP
B-Developing_anatomical_structure	1052	1058	embryo	embryo	NN	B-NP
O	1059	1069	compaction	compaction	NN	I-NP
O	1070	1073	and	and	CC	I-NP
O	1074	1085	development	development	NN	I-NP
O	1085	1086	,	,	,	O
O	1087	1097	suggesting	suggest	VBG	B-VP
O	1098	1100	an	an	DT	B-NP
O	1101	1110	essential	essential	JJ	I-NP
O	1111	1115	role	role	NN	I-NP
O	1116	1119	for	for	IN	B-PP
O	1120	1124	this	this	DT	B-NP
O	1125	1132	protein	protein	NN	I-NP
O	1133	1135	in	in	IN	B-PP
O	1136	1141	actin	actin	NN	B-NP
O	1142	1150	dynamics	dynamic	NNS	I-NP
O	1150	1151	.	.	.	O

O	1152	1156	Thus	Thus	RB	B-ADVP
O	1156	1157	,	,	,	O
O	1158	1165	genetic	genetic	JJ	B-NP
O	1166	1170	loss	loss	NN	I-NP
O	1171	1173	or	or	CC	O
O	1174	1184	inhibition	inhibition	NN	B-NP
O	1185	1187	of	of	IN	B-PP
O	1188	1192	BRK1	BRK1	NN	B-NP
O	1193	1195	is	be	VBZ	B-VP
O	1196	1202	likely	likely	JJ	B-ADJP
O	1203	1205	to	to	TO	B-VP
O	1206	1208	be	be	VB	I-VP
O	1209	1219	protective	protective	JJ	B-ADJP
O	1220	1227	against	against	IN	B-PP
B-Cancer	1228	1233	tumor	tumor	NN	B-NP
O	1234	1245	development	development	NN	I-NP
O	1246	1249	due	due	IN	B-PP
O	1250	1252	to	to	TO	B-PP
O	1253	1266	proliferation	proliferation	NN	B-NP
O	1267	1270	and	and	CC	I-NP
O	1271	1279	motility	motility	NN	I-NP
O	1280	1287	defects	defect	NNS	I-NP
O	1288	1290	in	in	IN	B-PP
O	1291	1299	affected	affect	VBN	B-NP
B-Cell	1300	1305	cells	cell	NNS	I-NP
O	1305	1306	.	.	.	O

